Access cutting-edge crohn's disease treatment through this clinical trial at a research site in Atlanta. Study-provided care at no cost to qualified participants.
Access crohn's disease specialists in Atlanta at no cost
This study follows strict safety protocols and ethical guidelines
All study-related crohn's disease treatment provided free
Vedolizumab is a medicine that helps to reduce inflammation and pain in the digestive system. In this study, children and teenagers with moderate to severe Crohn's disease will be treated with vedolizumab. The main aim of the study is to check if participants achieve remission after treatment with the vedolizumab. Remission means symptoms improve or disappear and an endoscopy shows no signs of inflammation. Participants will receive 3 infusions of vedolizumab over 6 weeks. Then, those who have
Sponsor: Takeda
Check if you qualify for this crohn's disease clinical trial in Atlanta, GA
If you're searching for crohn's disease treatment options in Atlanta, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Atlanta research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.